Clinical Trials on Non-squamous Non-small Cell Lung Carcinoma in Korea, Republic of
Total 1446 results
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited Kingdom, Taiwan, Brazil, China, India, Korea, Republic of, Hong Kong
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
AstraZenecaCompletedCarcinoma, Non-small-cell LungUnited States, Canada, Korea, Republic of, United Kingdom, Czech Republic
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
MedicalLogicKosin University Gospel HospitalUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Squamous Cell, Non-small-cell LungPoland, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Japan, Mexico, New Zealand, Romania, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom
-
TakedaRecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseKorea, Republic of
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIBKorea, Republic of
-
Yuhan CorporationThe Korean Academy of Tuberculosis and Respiratory DiseasesActive, not recruiting
-
Konkuk University Medical CenterYuhan CorporationRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNonsmall Cell Lung Cancer | Carcinoma，Non-Small-Cell Lung | Non-small-cell Lung Carcinoma | Lung Carcinomas, Non-Small-CellSpain, Australia, Belarus, Brazil, Bulgaria, Chile, China, Colombia, Czechia, Georgia, Greece, Hungary, Jordan, Lebanon, Malaysia, Mexico, Philippines, Poland, Romania, Russian Federation, Taiwan, Thailand, Turkey, Ukraine
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Boehringer IngelheimWithdrawnAnal Canal Squamous Cell CarcinomaKorea, Republic of
-
BayerRecruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Korea, Republic of, Israel, Japan, China, Australia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Israel, Italy, Spain, Hong Kong, Taiwan, Canada, France, Greece, Russian Federation, Czech Republic, Australia, Bulgaria, Germany, Thailand, Hungary, United Kingdom, Argentina, Brazil, Poland
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Clovis Oncology, Inc.TerminatedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | NSCLC | Lung Cancer | Metastatic Lung Cancer | SCLC | Stage IV Lung Cancer | Advanced Lung Cancer | Squamous Non-Small Cell Lung CancerUnited States, Italy, Germany, France, Spain
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaKorea, Republic of
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Asan Medical CenterCompletedPleural Effusion, Malignant | Non-small Cell CarcinomaKorea, Republic of
-
Yonsei UniversityActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Korea, Republic of
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Seoul National University HospitalUnknownHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
Samyang Biopharmaceuticals CorporationUnknownHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedHead and Neck NeoplasmKorea, Republic of
-
Bridge Biotherapeutics, Inc.TerminatedNSCLCKorea, Republic of
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungJapan, Korea, Republic of, Singapore
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Arcus Biosciences, Inc.Gilead SciencesRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Australia, United Kingdom, Taiwan, Spain, France
-
Georgetown UniversityRegeneron PharmaceuticalsNot yet recruitingNon-small Cell Lung Cancer Stage IIIUnited States
-
AbbVieCompletedSquamous Non-Small Cell Lung CancerUnited States, Australia, Austria, Belarus, Brazil, Canada, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, P... and more
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of